Equities

DOD Biotech PCL

DOD Biotech PCL

Actions
  • Price (THB)2.50
  • Today's Change0.16 / 6.84%
  • Shares traded449.30k
  • 1 Year change-34.90%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of THB
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue6785371,015
OPERATING EXPENSES
Cost of revenue total415397581
Selling, general and admin. expenses, total248158127
Depreciation/amortization--4.57--
Unusual expense(income)--40649
Other operating expenses, total(42)(11)(3.03)
Total operating expense621954744
Operating income57(417)272
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes49(424)265
Provision for income taxes28(79)32
Net income after taxes21(345)233
Minority interest(0.63)2.154.12
Net income before extra. Items20(343)237
Total extraordinary items(13)(55)(187)
Net income7.19(398)50
Inc.avail. to common excl. extra. Items20(343)237
Inc.avail. to common incl. extra. Items7.19(398)50
EPS RECONCILIATION
Basic/primary weighted average shares450411411
Basic/primary eps excl. extra items0.04(0.83)0.58
Basic/primary eps incl. extra items0.02(0.97)0.12
Dilution adjustment------
Diluted weighted average shares450411411
Diluted eps excl. extra items0.04(0.83)0.58
Diluted eps incl. extra items0.02(0.97)0.12
COMMON STOCK DIVIDENDS
DPS - common stock primary issue00--
Gross dividend - common stock----0
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental8.277.096.72
SUPPLEMENTAL INCOME
Depreciation, supplemental676567
Total special items--810154
NORMALISED INCOME
Normalized income before taxes49386419
Effect of special items on income taxes--28419
Income tax excluding impact of special items2820550
Normalized income after tax21182368
Normalized income avail. to common20184372
Basic normalized EPS0.040.450.91
Diluted normalized EPS0.040.450.91
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.